1446200-49-2 Usage
Molecular structure
The compound consists of a benzamido group, a thiazole group, and a benzoimidazole group.
Functional groups
It contains multiple functional groups, such as trifluoromethoxy, trifluoromethyl, and thiazole-4-carboxamide.
Fluorine content
The presence of multiple fluorine atoms in the molecule.
Reactivity
The high reactivity of the compound is attributed to the presence of fluorine atoms.
Potential applications
The compound may have potential use in pharmaceuticals or agrochemicals due to its complex structure and reactivity.
Precise structure
The specific structure and properties of the compound make it valuable for various applications.
Drug development
The compound could potentially be used as a drug, depending on its biological activity and pharmacological properties.
Pesticide development
It may also have potential as a pesticide, depending on its effectiveness against pests and environmental impact.
Organic synthesis
The compound could serve as a precursor in organic synthesis, enabling the creation of other complex molecules.
Further research
The specific function and potential applications of the compound would need to be investigated through research and testing to determine its suitability for various uses.
Check Digit Verification of cas no
The CAS Registry Mumber 1446200-49-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,4,4,6,2,0 and 0 respectively; the second part has 2 digits, 4 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1446200-49:
(9*1)+(8*4)+(7*4)+(6*6)+(5*2)+(4*0)+(3*0)+(2*4)+(1*9)=132
132 % 10 = 2
So 1446200-49-2 is a valid CAS Registry Number.
1446200-49-2Relevant articles and documents
2-Benzamido-N-(1H-benzo[d]imidazol-2-yl)thiazole-4-carboxamide derivatives as potent inhibitors of CK1δ/ε
Bischof, Joachim,Leban, Johann,Zaja, Mirko,Grothey, Arnhild,Radunsky, Barbara,Othersen, Olaf,Strobl, Stefan,Vitt, Daniel,Knippschild, Uwe
, p. 1577 - 1591 (2013/01/14)
In this study we identified two heterocyclic compounds (5 and 6) as potent and specific inhibitors of CK1δ (IC50 = 0.040 and 0.042 μM, respectively). Whereas compound 5 exhibited fivefold higher affinity towards CK1δ than to CK1ε (IC50/su
